Perspective Therapeutics appoints Juan Graham as CFO; Jonathan Hunt remains CAO

Perspective Therapeutics, Inc.

Juan Graham appointed CFO effective Jan 6, 2025; Jonathan Hunt steps down as CFO but stays CAO.
Graham brings 25 years experience; previously CFO of FibroGen, finance leadership at Johnson & Johnson.
Annual base salary $500k, target bonus 40%, signing bonus $80k, option grant of 400k shares with 4-year vest.
Severance: 12 months salary plus pro-rated bonus and COBRA upon termination without cause or for good reason.
Change of control: accelerated vesting of equity; severance of 12 months salary if not retained or termination within 12 months.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Jonathan Hunt

Chief Financial Officer

CATX · Perspective Therapeutics, Inc.

Effective: 2025-01-06
Successor: Juan Graham
Filed: January 6, 2025, 6:59 PM ET

As of the Effective Date, Mr. Jonathan Hunt will no longer serve as the Company’s Chief Financial Officer but will remain in his role as the Company’s Chief Accounting Officer and principal accounting officer.

Appointed

Juan Graham

Chief Financial Officer

CATX · Perspective Therapeutics, Inc.

Effective: 2025-01-06
Filed: January 6, 2025, 6:59 PM ET

On January 2, 2025, the Board of Directors (the “Board”) of Perspective Therapeutics, Inc. (the “Company”) appointed Mr. Juan Graham as the Company’s Chief Financial Officer and principal financial officer, in each case effective as of January 6, 2025

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Hunt changed role as Chief Financial Officer at Perspective Therapeutics, Inc..

Action: will no longer serve
Role: Chief Financial Officer

Exact text from the filing

As of the Effective Date, Mr. Jonathan Hunt will no longer serve as the Company’s Chief Financial Officer but will remain in his role as the Company’s Chief Accounting Officer and principal accounting officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Juan Graham was appointed as Chief Financial Officer at Perspective Therapeutics, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On January 2, 2025, the Board of Directors (the “Board”) of Perspective Therapeutics, Inc. (the “Company”) appointed Mr. Juan Graham as the Company’s Chief Financial Officer and principal financial officer, in each case effective as of January 6, 2025

View on SEC.gov

Perspective Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-25-001712

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.